Skip to content

PTC Therapeutics PTCT Net gains (losses) on investments

Net gains (losses) on investments at other companies

BridgeBio Pharma logo
BridgeBio PharmaBBIO
-$18.28M-17.5%
Biogen logo
BiogenBIIB
$19M+146%
ALN
Alnylam PharmaceuticalsALNY
Arrowhead Research logo
Arrowhead ResearchARWR
United Therapeutics logo
United TherapeuticsUTHR

Other financials

Income statement

See full
Revenue$272.6M-76.8%
Operating income$45.0M-95.4%
Net income-$2.8M-100%
EPS (diluted)-$0.03-100%

Balance sheet

See full
Cash & equivalents$834.0M-43.7%
Total debt$395.1M+0.1%
Total equity-$180.5M+2.9%
Total assets$2.9B+8.0%

Cash flow

See full
Operating cash flow-$59.0M-107%
CapEx$1.2M-30.6%
Free cash flow-$60.2M-107%

Valuation

See full
Market cap$6.55B+40.3%
Enterprise value$6.11B+77.3%
P/E
P/S7.9×+5.3×

Profitability

See full
Gross margin96%
Operating margin1.6%-38.7pp
Net margin42.3%+27.4pp
FCF margin39.1%+32.8pp

Returns & leverage

See full
Return on equity-216.7%
Debt / equity372.3×
Current ratio2.4×-1.5×

Where this comes from

Reported directly by PTC Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss.

The official record: PTC Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about PTC Therapeutics's net gains (losses) on investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is PTC Therapeutics's net gains (losses) on investments?
PTC Therapeutics (PTCT) reported net gains (losses) on investments of $1.21M in Q1 2026.
How has PTC Therapeutics's net gains (losses) on investments changed year-over-year?
PTC Therapeutics's net gains (losses) on investments increased by 56.8% year-over-year, from $774K to $1.21M.
What does net gains (losses) on investments mean?
Realized and unrealized gains/losses on investments removed from operating cash flow since they're investing-related.